patents

Recent Rosacea Blog Posts

Rhofade patents to last until 2031

Allergan lists the patents that it claims protects the intellectual property behind their prescription products. The following patents are claimed by Allergan to be associated with Rhofade. Rosacea News was watching the patents the were surfacing for oxymetazoline and noticed two of the claimed patents in 2012 – see Allergan Developing Oxymetazoline (AGN-199201/V-101) Cream Formulations. Given […]

Continue Reading

Gallo et al. patent Mast Cell Stabilizers

A 2014 patent application has surfaced that points to a potential new family of topical rosacea treatments. Drs. Gallo, Nardo and Muto have filed for a patent covering the role of mast cell stabilizers in treating rosacea. The patent also covers the inhibition and stimulation of vitamin D3, cathelicidin and serine protease, and how the […]

Continue Reading

Zenavod (DFD-09) is the new Generic Oracea – sadly no

News today that Dr. Reddy’s subsidiary Promius Pharma has gained tentative approval for their 40mg formulation of doxycycline for the papules and pustles of rosacea. Before we get too excited about the real possibility of the availability of a generic form of Oracea, the announcement tells us that the approval is “subject to an automatic […]

Continue Reading

Patent reveals possible Oracea successor

A patent application has emerged that proposed what might be an improvement to the doxycycline based Oracea treatment for rosacea. The patent seeks to create a sub-antibiotic dose formulation of doxycycline that is less susceptible to what it calls the `food effect’. Food effect refers to food-drug interactions which lead to either a decrease or […]

Continue Reading

Say goodbye to Generic Oracea

A recent ruling from the U.S. Patent and Trademark Office has put the final nail in coffin of the hopes for the availability of Generic Oracea. Rosacea sufferers will need to wait until that late 2020’s until the current patents protecting Oracea expire. Concerted efforts from Amneal Pharmaceuticals and Mylan Inc. have both failed to […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.